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The molecular basis of intraocular tuberculosis (TB) is not well understood. In this 
study, we investigated the role of two constituents of viable Mycobacterium 
tuberculosis – Early Secreted Antigenic Target-6 (ESAT-6), and mycobacterial 
RNA– in inflammasome activation in the retinal pigment epithelium (RPE) – a key 
site of inflammation in intraocular TB. 
We found that ESAT-6 induced caspase-1 activation and inflammasome priming in 
mouse RPE cells, significantly more in wild-type than in Tlr2/3/4/7/9-/-, Myd88-/- and 
Nlrp3-/- RPE cells. Sub-retinal ESAT-6 injection resulted in greater RPE degeneration 
in wild-type than Nlrp3-/- mice. In human ocular TB tissue sections, NLRP3 staining 
was noted in retina as well as RPE. Mycobacterial RNA, specifically its double 
stranded component, also induced caspase-1 activation, and the double stranded RNA 
was immunolocalized to human ocular TB sections. Our observations suggest that 
inflammasome activation in RPE by viable M. tuberculosis could potentially 
























Intraocular tuberculosis (TB) is a common cause of ocular inflammation in 
TB-endemic countries and is being increasingly reported from non-endemic countries 
[1,2]. Despite its widespread occurrence, several aspects of the disease including its 
molecular pathogenesis, remains unclear. The challenges in understanding 
pathogenesis of intraocular TB are primarily due to the paucibacillary nature of 
Mycobacterium tuberculosis infection in the eye [3]. In the current study, we have 
used mycobacterial products, associated with viable infection, to elucidate the 
molecular mechanisms of intraocular TB.  
Microbes or microbial products generate innate immune response in the host 
through several types of pathogen recognition receptors (PRRs) including Toll-like 
receptors (TLRs), NOD-like receptors (NLRs), C-type lectin receptors (CLRs) and 
various nucleic acid receptors [4]. These PRRs not only sense the microbial product, 
but also determine the extent of immune response depending on the presence or 
absence of microbial viability and virulence factors [5].  
M. tuberculosis has a wide range of virulence factors including lipids, cell 
envelope and secreted proteins, that could potentially activate inflammasomes [6]. 
Amongst these, the Early Secreted Antigenic Target-6 (ESAT-6), a 6kD protein, is 
secreted by live M. tuberculosis and has been demonstrated to be the most potent 
mycobacterial activator of the NLRP3 (NOD-like receptor family, pyrin domain 
containing 3) inflammasome [7]. ESAT-6 is also essential for colonization and 
granuloma formation in vivo [8]. Thus, ESAT-6 is not only a marker for 
mycobacterial viability, but also, a key virulence factor. However, it is unknown 
whether ESAT-6 activates NLRP3 in the eye, or whether NLRP3 is expressed in 













the innate immune system [5]. Once detected in the host cytosol, microbial RNA can 
activate NLRP3 inflammasome leading to caspase-1 dependent IL-1β production [9-
11]. However, it is not known whether RNAs accumulate in human intraocular TB, or 
whether RNA from M. tuberculosis can activate the inflammasome. 
In this study, we demonstrate NLRP3 inflammasome activation in human 
intraocular TB. We also show in in vivo and in vitro studies, that M. tuberculosis 
viability and virulence factors such as the secreted protein ESAT-6 and bacterial RNA 
(specifically double-stranded or dsRNA) can induce inflammasome activation in the 
retinal pigment epithelium (RPE). Finally, we demonstrate immunolocalization of 
dsRNA in human intraocular TB. 
 
2. Methods 
2.1. Immunostaining of human intraocular TB tissue sections  
Paraffin-embedded tissue sections of human ocular tuberculosis obtained from 
archival material of enucleated globes and diagnosed by IS6110 targeted real-time 
PCR or presence of acid-fast bacilli (n=5) or age-matched non-diseased controls 
(n=3) were first deparaffinized in xylene and decreasing concentrations of ethyl 
alcohol. The clinical diagnosis in the five human intraocular TB cases included 
panophthalmitis (n=2), panuveitis, choroiditis, and necrotising scleritis (all n=1). The 
sections were then depigmented with 0.25% potassium permanganate and 0.5% oxalic 
acid. Immunostaining was performed with mouse antibody against NLRP3 (1:100, 
Sigma Aldrich, St. Louis, MO) or dsRNA (1:1000, clone J2, English & Scientific 
Consulting, Szirák, Hungary) in later experiments, and the bound antibody detected 













Specificity of staining was ascertained by substituting isotype IgG for the primary 
antibody. 
 
2.2. Cell culture 
Human fetal and primary mouse RPE cells were isolated as previously 
described [18-19]. Mouse RPE cells were obtained from 6-8 week old C57BL/6J wild 
type (WT), Nlrp3-/-, TLR23479-/- and MyD88-/- mice. All knock out mice used in our 
study were back-crossed with C57BL6/J and were free of the Rd8 mutation. All cells 
were incubated at 37 oC at 5% CO2. Mouse cells were maintained in Dulbecco 
modified Eagles medium (DMEM), supplemented with 20% fetal bovine serum 
(FBS) and penicillin-streptomycin, while 10% FBS supplementation was used for 
human RPE cells. 
 
2.3. ESAT-6 treatment 
ESAT-6 (BEI Resources, USA, catalogue #NR-14868), dissolved in Hanks 
BSS, as per manufacturer’s instructions was used for treating RPE cell cultures. Cells 
with 80-90% confluence were treated for varying durations with 5µg of ESAT-6 per 
mL of culture medium in all experiments, except where other doses are mentioned. 
This dose was chosen based on reported use of 2.5µg dose of ESAT-6 for NLRP3 
inflammasome activation in THP-1 macrophages [7]. 
 
2.4. Mycobacterial RNA extraction and treatment 
M. tuberculosis H37Rv was grown in Middlebrook 7H9 supplemented with 
0.5% glycerol and 10% BD Middlebrook ADC (Fisher Scientific, Hampton, NH) and 













and 0.8) were harvested for RNA extraction using FastRNA Pro blue kit (MP 
Biomedicals, Santa Ana, CA) according to manufacturer’s instructions. RNA extracts 
were treated with Turbo DNase (Thermo Fisher Scientific, Waltham, MA) until DNA 
free. The samples were analysed by Nanodrop-1000, for confirming quality as well as 
for quantification. The RNA was divided into aliquots of 10 µg each and stored at -80 
oC. 
10 µg of exponential phase M. tuberculosis RNA, either untreated or 
following various enzymatic treatments (Table 1) was transfected into human or 
mouse RPE cells with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to 
the manufacturer’s instructions. A synthetically produced 300 nt long dsRNA, Alu 
RNA, that has been shown to cause NLRP3 dependent caspase-1 activation in the 
RPE (endogenously produced in age-related macular degeneration [14], was similarly 
transfected to be used as positive control. Enrichment of ssRNA from total RNA was 
performed using a ssRNA enrichment kit (Zymo, Irvine, CA).  
 
2.5. Western blotting 
After 24 hours incubation with either ESAT-6 or mycobacterial RNA, RPE 
cells were lysed with radioimmunoprecipitation assay (Sigma-Aldrich, St. Louis, 
MO) lysis buffer supplemented with protease inhibitor. Protein concentrations were 
measured with Bradford assay kit (Biorad, Hercules, CA) and equal amounts of 
protein samples were resolved by SDS-PAGE on 4-20% Tris-Glycine gels (Novex, 
Invitrogen, Carlsbad, CA). Proteins were then transferred to polyvinyledine difluoride 
membranes (Millipore, Burlington, MA), that were blocked for one hour with LI-
COR buffer and then incubated overnight at 4 oC, with anti-caspase-1 antibody 













instructions). The immunoreactive bands were identified on the Odessey CLx infrared 
imaging system (LI-COR, Lincoln, NE). Besides, ESAT6 treated RPE cells from WT, 
Nlrp3-/-, TLR23479-/- and MyD88-/- mice were also tested for NLRP3 protein 
abundance (1:1000, Sigma-Aldrich, St. Louis, MO). 
 
2.6. Real-time PCR 
We tested inflammasome priming at various time points following ESAT-6 
activation of mouse RPE cells. Total RNA was TRIzol extracted from RPE cells by 
following the manufacturer’s instructions. Equal quantities of RNA were reverse 
transcribed using Quantitect kit (Qiagen, Germantown, MD) and the resultant cDNA 
was amplified in the 7900 HT Fast real-time PCR system (Applied Biosystems, Foster 
City, CA) with SYBR Green detection system. Relative expressions of target genes 
were determined by the 2-DDCt method using the 18S rRNA housekeeping gene. 
Oligonucleotide primers specific for mouse Nlrp3 (forward, 5′-
ATGCTGCTTCGACATCTCCT-3′, and reverse, 5′-
AACCAATGCGAGATCCTGAC-3′), mouse Il-18 (forward, 5′-
GACAGCCTGTGTTCGAGGAT-3′, and reverse, 5′-
TGGATCCATTTCCTCAAAGG-3′), and mouse 18S rRNA (forward, 5′-
TTCGTATTGCGCCGCTAGA-3′, and reverse, 5′-CTTTCGCTCTGGTCCGTCTT-
3′) were used. 
 
2.7. Mice 
All animal experiments were approved by institutional review committee and 
carried out in accordance with the Association for Research in Vision and 













Research. Wild type (WT) C57BL/6J mice were purchased from Jackson Laboratory 
(Bar Harbor, ME). Nlrp3-/- mice have been previously described [9]. All knock out 
mice were backcrossed to C57BL6/J, and were confirmed to be free of Rd8 mutation.  
 
2.8. Sub-retinal injections of ESAT-6 
Subretinal injections of ESAT-6 (1µg/1µL) were given to WT and Nlrp3-/- 
mice anesthetized with 100 mg/kg ketamine hydrochloride (Ft. Dodge Animal 
Health), with a 34G needle and Exmire microsyringe (Ito Corporation, Fuji, Japan). 
Pupils were dilated with 1% tropicamide drops (Alcon Laboratories, Fort Worth, TX). 
 
2.9. Fundus photography and assessment of RPE degeneration 
Fundus photographs of dilated mouse eyes were taken seven days after sub-
retinal injection of ESAT-6, with TRC-50IX camera (Topcon, Tokyo, Japan) linked 
to a digital imaging system (Sony Corp., Tokyo, Japan). Following fundus 
photography, mice were sacrificed and whole mounts of RPE/ choroid were prepared 
that were fixed with 4% paraformaldehyde, and stained with rabbit polyclonal 
antibodies against mouse zonula occludens-1 (ZO-1, 1:100, Invitrogen, Carlsbad, 
CA), and visualized on immunofluorescence microscopy (SP-5, Leica, Exton, PA) 
with Alexa 594 (Invitrogen, Carlsbad, CA). Additional WT and Nlrp3-/- mice were 
euthanized, and retina and RPE were collected separately in RIPA buffer with 
proteinase inhibitor, and homogenized by sonication. Protein abundance was tested by 
western blot analysis, with antibodies against caspase-1 (1:1000, Invitrogen) and 
vinculin (1:1000, Sigma-Aldrich, St. Louis, MO) 
 













Seventy-two hours after sub-retinal injections of ESAT-6, we gave intravitreal 
injections of a near-infrared fluorophore (NIRF, Ex: 790 Em: 800) conjugated pan-
caspase probe (VAD-fmk). Fundus photos and near-infrared fluorescent imaging were 
acquired using Topcon TRC-50IX, 4 hours following the injection.  
 
 
3. Results  
 
3.1. ESAT-6 induces dose-dependent activation of caspase-1, and cytotoxicity 
in mouse RPE cells: We tested the effect of mycobacterial viability and 
virulence associated factors – ESAT-6 and bacterial RNA in inducing 
inflammasome activation in RPE cells in vitro and in vivo.  We selected the 
RPE for our in vitro studies, as it is commonly involved in intraocular TB 
(multifocal serpiginoid choroiditis) and has been predicted to be the site for 
preferential localization of M. tuberculosis in the eye [12-13].  
We found caspase-1 activation in mouse RPE cells after treatment with a 
range of ESAT-6 doses (Figure 1A). These results suggest that RPE cells are 
susceptible to innate immune activation by M. tuberculosis secreted protein 
ESAT-6. In addition, we examined inflammasome priming at various time 
points after ESAT-6 activation. We noted significantly increased NLRP3 and 
IL-18 mRNA abundance only after 24 hours of treatment (Figure 1B-C). 
These results suggest that RPE cells are able to mount an innate immune 














3.2. ESAT-6-induced caspase-1 activation is dependent on TLR signaling, 
NLRP3 and MyD88: We next investigated the upstream pathways for 
caspase-1 activation. Previous studies in mice and THP-1 cells have 
implicated NLRP3 activation as important inflammatory mediators activated 
by ESAT-6 [7]. Consistent with these previous findings, we found that 
ESAT-6-induced caspase-1 activation was dramatically reduced in Tlr23479-/-
, Myd88-/- and Nlrp3-/-  RPE cells compared to wild-type RPE cells (Figure 
1D).   
 
Figure 1. ESAT-6 induces dose-dependent activation of caspase-1, and 
cytotoxicity in mouse retinal pigment epithelium (RPE) cells. (A) Western blotting 
for active caspase-1 protein levels after treatment with 5, 10 and 15µg of ESAT-6. 
Priming of NLRP3 analyzed by mRNA abundance of NLRP3 (B) and IL-18 (C) after 
0, 12 and 24 hours of treatment with 10µg of ESAT-6. (D) Absent NLRP3 protein, 













Nlrp3 deficient cells, as compared to wild type (WT) RPE cells, suggesting role of 
these mediators in NLRP3 inflammasome and caspase-1 activation. 
 
3.3. Sub-retinal injection of ESAT-6 induces NLRP3 dependent RPE 
degeneration: The RPE is a common site of inflammation in some forms of 
intraocular TB such as multifocal serpiginoid choroiditis [12]. In mice, sub-
retinal injection of ESAT-6, but not vehicle BSS, resulted in RPE 
degeneration around the injected area (Figure 2A). The extent of degeneration 
was confirmed on ZO-1-stained RPE flat mounts that revealed extensive 
distortion of cell morphology in ESAT-6 treated eyes compared with regular 
hexagonal cells in vehicle treated eyes (Figure 2B). Furthermore, in vivo 
imaging with a pan-caspase probe revealed increased intensity of the active 
probe in ESAT-6 treated eyes as compared to vehicle treated eyes (Figure 
2C). Moreover, eyes from Nlrp3-/- mice were protected from ESAT-6-induced 
RPE degeneration compared to wild-type mice (Figure 2D). This is consistent 
with the finding (Figure 1F) that caspase-1 activation was dependent on 
NLRP3. Further indicating that ESAT-6 causes RPE degeneration via the 
NLRP3 inflammasome, protein extracted from both retina and RPE of ESAT-
6 injected mice showed significantly higher activated caspase-1 (p20) in wild 















Figure 2. Sub-retinal injection of ESAT-6 induces NLRP3 dependent RPE 
degeneration. RPE degeneration after ESAT-6 injection as seen on (A) color fundus 
photograph. n=5 (B) zonula occludens-1 staining, n=4 and (C) bioimaging with pan-
caspase probe. n=5. (D) Significantly reduced RPE degeneration in Nlrp3 deficient 
mice, as compared to wild type (WT) mice. n=3 (E) Western blotting of pooled retina 
and RPE extracts showing dramatically reduced caspase-1 activation in Nlrp3 
deficient mice 
 
3.4. Double-stranded RNA from M. tuberculosis induces NLRP3-dependent 
caspase-1 activation in RPE: We have previously demonstrated that 
accumulation of an endogenous RNA (Alu RNA) induces NLRP3 













advanced form of age-related macular degeneration [14]. As such, we used 
Alu RNA as a positive control for caspase-1 activation. Transfection of M. 
tuberculosis total RNA also activated caspase-1 in primary human RPE cell 
cultures (Figure 3A). This finding is consistent with previous studies that 
demonstrated the immunological potential of bacterial RNA delivered into 
the cytosol of various types of eukaryotic cells [9-11]. 
To determine the characteristics of M. tuberculosis RNA that activate 
caspase-1, we treated M. tuberculosis total RNA with different ribonucleases 
(RNases) prior to incubation with RPE cell cultures (Table 1). While 
treatment with RNase I (which specifically degrades single-stranded RNA 
(ssRNA)) did not alter Caspase-1 activation, treatment with RNase III (which 
specifically degrades double-stranded RNA (dsRNA)) completely abrogated 
the response (Figure 3B). These data suggest that dsRNA from M. 
tuberculosis is responsible for caspase-1 activation. Further supporting this 
concept, ssRNA enriched from mycobacterial total RNA did not activate 
caspase-1 (Figure 3C). It is likely that caspase-1 activation by mycobacterial 
RNA in RPE cells is also mediated by NLRP3, as has been demonstrated by 
previous studies [9-11].   
Table 1: Summary of various methods used to treat Mycobacterium tuberculosis 
RNA (10µg) prior to transfection into human retinal pigment epithelium  
Treatment  Dose Duration 
RNase I 
(Life Technologies) 
5U 30 minutes 
RNase III 
(Life Technologies) 















As per manufacturer’s instructions 
 
 
We also detected dsRNA immunoreactivity in paraffin embedded tissue 
sections of patients with ocular tuberculosis by using the J2 antibody that recognizes 
long dsRNA [15]. dsRNA was detected in various cell types including the RPE in 
ocular tuberculosis tissue sections (4/4), but not in normal age-matched controls (refer 
to our earlier publication [14]) (Figure 3D). It is tempting to speculate that the J2-
positive signal is mycobacterium-derived dsRNA; however, it is also possible that the 
observed dsRNA is host-derived, and is induced by bacterial infection or 
inflammation.  Future work will be required to determine the source of dsRNA 















Figure 3: Double-stranded RNA from exponential phase Mycobacterium 
tuberculosis (Mtb) H37Rv cultures activates caspase-1 in the retinal pigment 
epithelium (RPE) (A) Immunoblot analysis of caspase-1 activation 24 hours after 
treatment with two different doses of Mtb RNA. Alu RNA (10 µg) was used as 
positive control while phosphate buffered saline (PBS) and lipofectamine were used 
as negative controls. (B) Caspase-1 activation in human RPE cells exposed to 10µg 
Mtb RNA previously treated with RNase I or RNase III (C) Caspase-1 activation in 
hRPE cells exposed to Mtb RNA previously treated with RNase III, or to single-
stranded RNA-enriched Mtb RNA (D) Immunolocalization of double-stranded RNA 
in human intraocular TB (n=4) with J2 antibody in retinal pigment epithelium (purple, 
arrows), but not with isotype antibody. 
 
3.5. NLRP3 activation in human eyes with intraocular TB: In further support 
of the role for NLRP3 in intraocular TB, we found immunoreactivity to 
NLRP3 in retina, RPE, choroid and iris from human intraocular TB tissue 
(Figure 4). These tissue sections had been obtained from enucleated eyes with 
bacteriologically confirmed TB. Increased abundance of NLRP3 protein in 
diseased tissues as compared to controls was suggestive of involvement of 
this pathway in intraocular TB. Interestingly, we found significant NLRP3 
immunoreactivity in the photoreceptor layers of the retina. This needs to 
investigated in future studies as a mechanism of visual loss in intraocular TB 















Figure 4. Immunolabeling of human intraocular TB, showing staining for NLRP3 
(arrowheads, top panel) in retina, RPE, choroid (with detached RPE) and iris. n=4. No 
staining was seen with isotype IgG antibody. Focal area of necrosis in the RPE 
(arrow) is shown in the lower panel for RPE antibody. 
 
4. Discussion 
Inflammasome activation has been described previously in various forms of 
ocular inflammation [14,16]. Although M. tuberculosis is known to activate the 
NLRP3 inflammasome in systemic TB, the role of inflammasome activation in 
intraocular TB was not known. Our study demonstrates the involvement of the 
NLRP3 inflammasome in intraocular TB. We have demonstrated inflammasome 
activation by two markers of M. tuberculosis viability – a secreted protein, ESAT-6 
and mycobacterial RNA. We found caspase-1 protein abundance and increased 
NLRP3 expression after ESAT-6/ mycobacterial RNA treatment. In addition, caspase-













degeneration and caspase-1 activation in RPE, following sub-retinal injection of 
ESAT-6. Both were significantly reduced in Nlrp3-/- mice. Finally, we provided direct 
evidence of NLRP3 by immunostaining in human ocular TB. 
Primary involvement of RPE has been suggested in imaging studies in 
serpiginous-like choroiditis, a common form of intraocular TB. Histopathological 
study has demonstrated presence of M. tuberculosis within the RPE in an enucleated 
eye with panuveitis [13]. Most recently, RPE cells have been shown to phagocytose 
M. tuberculosis at rates similar to THP-1 macrophages [17]. Also, viable 
mycobacteria persisted longer in RPE cells than in THP-1 cells. Together, these 
observations suggest that RPE cells can be a potential reservoir for viable M. 
tuberculosis in the eye. Thus, inflammasome activation in the RPE by viable 
mycobacteria could be crucial for pathogenesis of intraocular TB.  
A novel finding of our study is the relationship between intraocular 
inflammation and bacterial RNA. We found that RNase III sensitive RNA (double-
stranded), but not RNase I-sensitive RNA (single-stranded) from M. tuberculosis, 
activated caspase-1 in RPE cells. Previous studies have documented similar 
differential responses of microbial RNA upon treatment with different RNases [9-11]. 
For example, Sander et al. found that E. coli RNA-induced IL-1β and lactate 
dehydrogenase production was abrogated in THP-1 macrophages after RNase I and 
III treatment, or with RNase III treatment alone, though they did not highlight the 
specific role of bacterial dsRNA in inflammasome activation [10]. We did not study 
the role of various bacterial RNA components (mRNA, rRNA and tRNA) 
individually, though previous reports show different responses to these RNA 
components in human and murine macrophages [11]. mRNA appears to be the only 













inflammasomes in human macrophages. We speculate that the differential response to 
double- or single-stranded RNA not only varies between different hosts but also 
between different cell types in the same host. 
Our results would be stronger if replicated with live M. tuberculosis, and also 
compared with that from dead organisms. Additional studies with adoptive transfer of 
ESAT-6 specific T-cells, from immunized mice to healthy mice would help in ruling 
out the possibility of activated M. tuberculosis specific T-cells from non-ocular sites 
of infections migrating to the eye to cause uveitis. We plan to work on this interesting 
hypothesis in future studies. There were also incongruities between our experimental 
and human data, that we could not overcome in the current study. For example, we 
found clear evidence of RPE cell death in vitro and in vivo, while such was not 
evident in human tissue sections. This might be due to the extremely paucibacillary 
nature of human eye infections, and correspondingly low levels of mycobacterial 
proteins/ RNA. Similarly, mere demonstration of NRLP3 inflammasome in human 
tissues is not equivalent to its activation/oligomerization. These too need to be 
addressed in future studies.  
In conclusion, our study links inflammasome activation in intraocular TB to 
mycobacterial viability. This association reiterates the importance of anti-
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• Molecular mechanisms of ocular tuberculosis are unknown 
• We investigated inflammasome activation by viable mycobacterial constituents in the 
eye 
• ESAT-6 induced NLRP3-dependent caspase-1 activation in retinal pigment 
epithelium(RPE) 
• Mycobacterial double-stranded RNA(dsRNA) also activated caspase-1 in RPE 
• NLRP3 and dsRNA were immunolocalised in human ocular TB sections 
